Delivery Order SPE2DB22D2206-SPE2DB25FKC18
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of AmBisome 50 mg vials, a critical antifungal medication used in military and federal healthcare systems. This competitively awarded, non-set-aside contract is valued at $16,184.74 with a firm fixed price structure and an ultimate completion date of August 5, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of AmBisome 50 mg vials, a critical antifungal medication used in military and federal healthcare settings. This non-set-aside, competitively awarded delivery order carries a ceiling value of $1,291.80 under firm fixed price terms, with a completion date of September 22, 2025. The contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $9,532.30 delivery order to AmerisourceBergen Drug Corp for 50 mg vials of AmBisome, a critical antifungal medication used in military and federal healthcare systems. This firm fixed-price contract, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $2,906.55 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of AmBisome 50 mg vials. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 8, 2025. AmBisome is an antifungal medication used to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 1, 2025, for the supply of AmBisome 50 mg vials, a specialized antifungal pharmaceutical product. This competitively awarded, non-set-aside contract carries a ceiling value of $7,741.00 with firm fixed pricing and an ultimate completion date of September 2, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of AmBisome 50 mg vials, a specialized antifungal medication used in military and federal healthcare systems. This competitively awarded, firm fixed-price delivery order has a ceiling value of $10,099.14 with an ultimate completion date of August 25, 2025. The contract was fulfilled by AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of AmBisome 50 mg vials, a specialized pharmaceutical product used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $11,016.77, was competitively awarded without set-aside designation and is scheduled for completion by August 8, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 50 mg vials of the pharmaceutical product AmBisome. The contract has a completion date of February 16, 2024 and a potential value of $2,517.84. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,975.20 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4559476979 AMBISOME 50 MG VIALS. This contract has an ultimate completion date of January 3, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- This federal contract award is for the delivery of AmBisome 50 mg vials, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,923.48 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., holds with the DLA Troop...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKC18Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,010.44 to AmerisourceBergen Drug Corp for 50 mg vials of AmBisome, an antifungal medication used primarily in military and federal healthcare settings. This firm fixed price delivery order, with an ultimate completion date of September 25, 2025, represents a non-competitive procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order will be fulfilled from the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen operates as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is a child contract under AmerisourceBergen's prime IDC with DLA valued at $999,999,999.00 and extending through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. Through this flexible contracting structure, AmerisourceBergen supplies critical medical products to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning the company as a key vendor within the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 9/24/25 |